Results

Total Results: 1,147 records

Showing results for "event".

61. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
    January 15, 2002 - In this analysis, the estimated annual excess risk with aspirin was 0.1 event per 1,000 users. … Detection of events, definition of a "significant" bleeding event, and reporting of location of upper … of aspirin, a reduction in nonfatal myocardial infarction, cannot be directly equated to an adverse event … Our estimates of expected event rates and these mean utility values can provide an initial framework … rate of 0.8 percent per year for CVD; this is equivalent to an event rate of 0.6 percent per year for

62. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/VKGPkVjto7K4yfUHBKEHBA
    January 01, 2025 - char- acteristics that affect the likelihood of experiencing a specific therapy- associated adverse event … Women Outcome Absolute Event Rate Difference per 10 000 Woman-Years (95% CI) Harms Breast cancer … Estimated Event Rate Difference Associated With Estrogen Use Alone vs Placebo in Postmenopausal Women … Outcome Absolute Event Rate Difference per 10 000 Woman-Years (95% CI) Harms Dementia (probable)a … However, event rates in these studies were low, and the length of follow-up was short (<2 years), which

63. A and B Recommendations | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-and-b-recommendations
    December 01, 2021 - aged 40 to 75 years with no history of cvd, 1 or more cvd risk factors, and a calculated 10-year cvd event … diabetes, hypertension, or smoking); and 3) they have a calculated 10-year risk of a cardiovascular event … Identification of dyslipidemia and calculation of 10-year CVD event risk requires universal lipids screening

64. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - derived from the ACC/AHA pooled cohort equations to predict 10-y risk for first atherosclerotic CVD event … The calculator predicts 10-year risk for a first hard atherosclerotic CVD event, defined as nonfatal … and proton-pump inhibitor use may decrease the likelihood of hospitalization from a major bleeding event … aspirin use during ages 50 to 59 years and continuing unless contraindicated by an adverse bleeding event … aspirin use during ages 60 to 69 years and continuing unless contraindicated by an adverse bleeding event

65. Evidence Directions for Primary Care Interventions to Prevent Child Maltreatment (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/tpsQcTR2sDok_YELXgBHFb
    July 23, 2024 - youth self-report and the development and validation of composite outcomes with potentially higher event

66. Archived: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-december-2017
    December 12, 2017 - individual characteristics that affect the likelihood of experiencing a specific therapy-associated adverse event … Table 1 and Table 2 show the estimated absolute event rate differences associated with the use of … However, event rates in these studies were low, and the length of follow-up was short (<2 years), which … Estimated Event Rate Difference Associated With Estrogen Use Alone vs Placebo in Postmenopausal Women … Outcome Absolute Event Rate Difference

67. Draft Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/statin-use-primary-prevention-cardiovascular-disease-adults
    July 09, 2020 - estimated CVD risk, comorbidities Populations younger than age 18 years or with a prior CVD-related event

68. Recommendation: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening
    March 02, 2020 - interferon-containing regimens to 8 to 12 weeks. 1 In DAA trials (33 trials; n = 7167) with adverse event … data, the pooled rate of any adverse event was 73.3%. 1 Rates of serious adverse events (1.9%) and … Five trials reported no withdrawals due to adverse events; 1 trial reported a serious adverse event ( … The rate of any adverse event was 27% in 1 trial and 71% to 84% in 4 trials. … Specific adverse event rates across trials ranged from 3% to 48% for headache (7 trials), 5% to 53% for

69. Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    April 26, 2022 - The nonsignificance of the increase in total hemorrhagic stroke may be due to low event rates (0.13% … Most trials reported time-to-event analyses for CVD outcomes. 5-7 , 26 , 28 , 29 , 31 , 32 , 43 , 45 … , 53 In cases in which time-to-event analyses suggested benefit for individual CVD outcomes, benefit … USPSTF 11 as well as several other recent meta-analyses, in demonstrating that small absolute CVD event … comparing pre–ATP III and post–ATP III trials, 115 the sensitivity analyses showed that major CVD event

70. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/by8VJVre6h6BmadrGxaFMM
    April 01, 2016 - ciation (ACC/AHA) pooled cohort equations to predict 10-year risk for first hard atherosclerotic CVD event … derived from the ACC/AHA pooled cohort equations to predict 10-y risk for first atherosclerotic CVD event … The calculator predicts 10-year risk for a first hard athero- sclerotic CVD event, defined as nonfatal … The tool presumes a baseline incidence rate of upper GI complications of 1 event per 1000 person-years … Hemorrhagic stroke was a rare event; 15.5% of to- tal strokes reported in the trials were hemorrhagic

71. Final Research Plan: Screening for Atrial Fibrillation | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-atrial-fibrillation
    July 16, 2020 - lead or less than 12-lead ECG Intermittent or continuous ambulatory ECG such as Holter monitoring, event … provider, with or without ECG machine algorithm interpretation Intermittent ambulatory ECG such as event

72. Final Research Plan: Atrial Fibrillation: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/atrial-fibrillation-screening
    July 16, 2020 - lead or less than 12-lead ECG Intermittent or continuous ambulatory ECG such as Holter monitoring, event … provider, with or without ECG machine algorithm interpretation Intermittent ambulatory ECG such as event

73. Evidence Summary: Nonpregnant Adolescents and Adults: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nonpregnant-adolescents-and-adults1/human-immunodeficiency-virus-hiv-infection-screening
    June 11, 2019 - Relative risks (RRs) were calculated based on reported event rates, to calculate absolute risk differences … , 0.31-0.63) All-cause mortality: RR, 0.58 (95% CI, 0.29-1.18) Mortality due to AIDS-related event … event: RR, 0.28 (95% CI, 0.16-0.51) NR TEMPRANO ANRS Daniel et al, 15 2015 All-cause … : RR, 0.25 (95% CI, 0.03-2.20) Any AIDS-related event: RR, 0.65 (95% CI, 0.44-0.95) Tuberculosis … Cell Count at ART Initiation, /mm 3 All-Cause Mortality, HR/RR (95% CI) AIDS-Related Events Event

74. Evidence Summary: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-b-virus-infection-screening
    December 15, 2020 - events (4 trials, n = 802; RR, 0.92 [95% CI, 0.45 to 1.85]; I 2 = 0%), 17 , 19 , 20 , 27 any adverse event … 187.17]). 22 Another trial found interferon associated with markedly increased risk of any adverse event … 0.86 to 6.74]), withdrawal due to adverse events (RR, 4.01 [95% CI, 0.86 to 18.73]), and any adverse event … (RR, 1.58 [95% CI, 1.41 to 1.78]) vs lamivudine, though only the estimate for any adverse event was … adverse events: 3 trials, n = 496; RR, 4.44 (95% CI, 0.95-20.77); I 2 =0% 22 , 24 , 27 Any adverse event

75. Final Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/statin-use-in-adults-preventive-medication
    November 05, 2020 - comorbidities, socioeconomic status Populations younger than age 18 years or with a prior CVD-related event

76. Evidence Summary: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/abdominal-aortic-aneurysm-screening
    December 10, 2019 - for Aortic Aneurysm Repair [EUROSTAR]) ( Table 4 ). 40 , 71 Only the ADAM trial reported adverse event … , nor were the overall complication rates significantly different ( Table 3 ). 51 Furthermore, the event … : 9 (8.3) Serious pulmonary event: 1 (0.9) Serious renal event: 1 (0.9) PIVOTAL … : 17 (5.3) Serious pulmonary event: 4 (1.2) Serious renal event: 6 (1.9) Control: … Serious cardiac event: 9 (8.3) Serious pulmonary event: 1 (0.9) Serious renal event: 1 (0.9

77. Archived: Final Evidence Summary: Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary41/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index
    September 03, 2013 - The event rates for myocardial infarction or CAD death are two thirds to three fourths those for total … higher category, minus those moving to a lower category, plus the proportion who will not have a CVD event … was older (median age, 73.5 years) and had higher rates of CAD events (16% of participants had a CAD event … The intermediate-risk category was defined as a 6% to 19% risk for a hard CVD event within 10 years. … a larger cohort who were at intermediate risk, defined as having a 6% to 19% chance of having a CAD event

78. The Ankle–Brachial Index for PAD and CVD Prediction Among Asymptomatic Adults: A Systematic Evidence Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_Fp-7sDqohFNj_9WF3_tY
    September 01, 2013 - The event rates for myocardial infarction or CAD death are two thirds to three fourths those for total … appro- priately reclassified and is calculated as the proportion of individuals who will have a CVD event … higher category, minus those moving to a lower category, plus the proportion who will not have a CVD event … older (me- dian age, 73.5 years) and had higher rates of CAD events (16% of participants had a CAD event … The intermediate-risk category was de- fined as a 6% to 19% risk for a hard CVD event within 10 years

79. Archived: Final Evidence Summary: Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary41/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index-2013
    September 03, 2013 - The event rates for myocardial infarction or CAD death are two thirds to three fourths those for total … higher category, minus those moving to a lower category, plus the proportion who will not have a CVD event … was older (median age, 73.5 years) and had higher rates of CAD events (16% of participants had a CAD event … The intermediate-risk category was defined as a 6% to 19% risk for a hard CVD event within 10 years. … a larger cohort who were at intermediate risk, defined as having a 6% to 19% chance of having a CAD event

80. Archived: Final Research Plan: Carotid Artery Stenosis: Screening, December 2007 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan36/carotid-artery-stenosis-screening-december-2007
    January 23, 2014 - significant neurologic symptoms referable to the carotid artery and have not experienced a cerebrovascular event … of subjects who never had symptoms referable to the carotid artery and never had a cerebrovascular event